Archives

by in
Entry Author Date Location
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Allozyne Lands $2,002,000 New Financing Round 06/04/12 Seattle
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics 03/21/12 Seattle
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan 01/03/12 Seattle
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles 12/23/11 Seattle
Allozyne Receives New Round 12/23/11 Seattle
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ 06/22/11 Seattle
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News 01/20/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders 12/13/10 San Diego
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Allozyne’s Next Drug, Made to Kill Two Birds With One Stone, Being Prepped for Clinic 11/16/10 Seattle
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Our Top 20 Stories of the Third Quarter: What’s Making Waves in the NW’s Tech and Biotech Sectors 09/30/10 Seattle
Lee Hood & Team Moving to South Lake Union, Mirina Vs. Marina, Trubion Gets Acquired, & More Seattle-Area Life Sciences News 08/19/10 Seattle
Allozyne Inks Sigma-Aldrich Deal 08/12/10 Seattle
Biotech on a Shoestring: How Companies Are Pinching Pennies in the “New Reality” 07/21/10 Seattle
Allozyne Breaks Silence, Accelerator’s Mini-Golf Hijinks, Maveron’s Vision for Primary Care, & More Seattle-Area Life Sciences News 07/15/10 Seattle
Allozyne Licenses Scripps Chemistry 07/14/10 Seattle
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline 07/14/10 Seattle
Dendreon Makes History, Microsoft Tries Open-Source Biology, an OVP IPO Is Brewing, & More Seattle-Area Life Sciences News 05/06/10 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.